Pablo Albasanz-García/LinkedIn
Jan 14, 2026, 11:26
Pablo Albasanz-García and Colleagues on Anticancer Treatment-Induced Arterial and Venous Thrombosis
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Mechanisms of anticancer treatment-induced arterial and venous thrombosis
This narrative review explores how cancer therapies trigger blood clots through coagulation activation, vascular damage, tumor cell death materials, and inflammation—crucial for developing better thrombosis prevention strategies.
Authors: Pablo Albasanz-García, Mark Ward, Lucy Norris
Check out this article.”
Article: Mechanisms of anticancer treatment-induced arterial and venous thrombosis
Authors: Pablo Albasanz-García, Mark P. Ward, Lucy A. Norris
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 14, 2026, 11:38Khokon Miah Akanda Shares A major 4-Guideline Comparison on BP Management in Stroke
-
Jan 14, 2026, 11:16ISTH 2026: Laurent Bertoletti To Serve as Vice Theme Leader for VTE
-
Jan 14, 2026, 11:08Leni von Bonsdorff Invites You to Hear and Learn The Latest News in The Plasma Field
-
Jan 14, 2026, 05:56Arun V J on The “Whole Blood” Nostalgia Trap
-
Jan 13, 2026, 16:38Caitlin Raymond: Understanding TAMOF as a TTP-Like Process
-
Jan 13, 2026, 15:22John Amako: Childhood to Adulthood Management Approach for SCD
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription
-
Jan 13, 2026, 10:53Lena Volland on Ming Y Lim’s Example of Designing Care Models for WGBD Community With Intention